BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Duvic M, Donato M, Dabaja B, Richmond H, Singh L, Wei W, Acholonu S, Khouri I, Champlin R, Hosing C. Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome. J Clin Oncol. 2010;28:2365-2372. [PMID: 20351328 DOI: 10.1200/jco.2009.25.8301] [Cited by in Crossref: 118] [Cited by in F6Publishing: 124] [Article Influence: 9.1] [Reference Citation Analysis]
Number Citing Articles
1 Fay CJ, Awh KC, LeBoeuf NR, Larocca CA. Harnessing the immune system in the treatment of cutaneous T cell lymphomas. Front Oncol 2022;12:1071171. [PMID: 36713518 DOI: 10.3389/fonc.2022.1071171] [Reference Citation Analysis]
2 Canu D, Pham-Ledard A, Ouhabrache N, Beylot-Barry M. Changes in total skin electron beam therapy modalities for mycosis fungoides: A single-centre study. Ann Dermatol Venereol 2022:S0151-9638(22)00030-8. [PMID: 35595588 DOI: 10.1016/j.annder.2022.02.006] [Reference Citation Analysis]
3 Canu D, Beylot-barry M, Ingen-housz-oro S, Ouhabrache N, To N. Place de la radiothérapie dans le traitement des lymphomes cutanés. Annales de Dermatologie et de Vénéréologie - FMC 2022;2:238-244. [DOI: 10.1016/j.fander.2021.08.006] [Reference Citation Analysis]
4 Smits K, Quint K, Vermeer M, Daniëls L, Willemze R, Jansen P, Jansen W, Neelis K. Total skin electron beam therapy for cutaneous T-cell lymphomas in the Netherlands: A retrospective analysis of treatment outcomes and selection for high or low dose schedule. Clinical and Translational Radiation Oncology 2022;33:77-82. [DOI: 10.1016/j.ctro.2021.12.001] [Reference Citation Analysis]
5 Franke G, Dumann K, Jentzsch M, Monecke A, Doehring C, Nehring-vucinic C, Schwind S, Niederwieser D, Platzbecker U, Ziemer M, Vucinic V. Case Report: Graft Versus Tumor Effect After Non-Myeloablative Allogeneic Stem-Cell Transplantation in a Patient With Brentuximab-Vedotin Refractory Sezary Syndrome. Front Oncol 2021;11:749691. [DOI: 10.3389/fonc.2021.749691] [Reference Citation Analysis]
6 Weng WK, Arai S, Rezvani A, Johnston L, Lowsky R, Miklos D, Shizuru J, Muffly L, Meyer E, Negrin RS, Wang E, Almazan T, Million L, Khodadoust M, Li S, Hoppe RT, Kim YH. Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphoma. Blood Adv 2020;4:4474-82. [PMID: 32941647 DOI: 10.1182/bloodadvances.2020001627] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
7 de Masson A, Peffault de Latour R, Ram-wolff C, Bagot M. Traitement des lymphomes T cutanés par allogreffe de cellules souches hématopoïétiques. Annales de Dermatologie et de Vénéréologie - FMC 2021;1:187-192. [DOI: 10.1016/j.fander.2020.07.004] [Reference Citation Analysis]
8 Willemze R, Theurich S, Schlaak M. Indolent Cutaneous T-Cell Lymphomas. Hematologic Malignancies 2021. [DOI: 10.1007/978-3-030-55989-2_14] [Reference Citation Analysis]
9 Bolcato V, Barruscotti S, DE Silvestri A, Tomasini CF, Brazzelli V. Sézary Syndrome: a clinico-pathological study of 9 cases. Ital J Dermatol Venerol 2021;156:73-83. [PMID: 33084262 DOI: 10.23736/S2784-8671.19.06403-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Dumont M, Peffault de Latour R, Ram-Wolff C, Bagot M, de Masson A. Allogeneic Hematopoietic Stem Cell Transplantation in Cutaneous T-Cell Lymphomas. Cancers (Basel) 2020;12:E2856. [PMID: 33023002 DOI: 10.3390/cancers12102856] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
11 Kanda-Kato M, Yoshioka S, Ishikawa T. Haploidentical Hematopoietic Cell Transplantation Using Posttransplant Cyclophosphamide for Sézary Syndrome. Case Rep Oncol 2020;13:1053-8. [PMID: 33082748 DOI: 10.1159/000509347] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 Querfeld C, Rosen ST, Duvic M. Cutaneous T-Cell Lymphoma and Cutaneous B-Cell Lymphoma. Abeloff's Clinical Oncology 2020. [DOI: 10.1016/b978-0-323-47674-4.00104-3] [Reference Citation Analysis]
13 Welborn M, Duvic M. Antibody-Based Therapies for Cutaneous T-Cell Lymphoma. Am J Clin Dermatol 2019;20:115-22. [PMID: 30430444 DOI: 10.1007/s40257-018-0402-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
14 Scarisbrick J. Staging of Mycosis Fungoides and Sézary Syndrome: Time for an Update? EMJ Hematol 2018. [DOI: 10.33590/emjhematol/10313097] [Reference Citation Analysis]
15 Nicolay JP, Goerdt S. Kutane Lymphome beim alten und geriatrischen Patienten. Geriatrische Onkologie 2018. [DOI: 10.1007/978-3-662-48727-3_43] [Reference Citation Analysis]
16 Kinoshita-Ise M, Ouchi T, Izumi E, Kawaguchi O, Nagao K, Amagai M, Funakoshi T. Combination of low-dose total skin electron beam therapy and subsequent localized skin electron beam therapy as a therapeutic option for advanced-stage mycosis fungoides. Clin Exp Dermatol 2018;43:437-40. [PMID: 29266332 DOI: 10.1111/ced.13347] [Reference Citation Analysis]
17 van Santen S, Vermeer MH, Willemze R. Classification and recommended treatment options for folliculotropic mycosis fungoides. Expert Opinion on Orphan Drugs 2017;6:35-45. [DOI: 10.1080/21678707.2018.1406796] [Reference Citation Analysis]
18 Berg S, Villasenor-Park J, Haun P, Kim EJ. Multidisciplinary Management of Mycosis Fungoides/Sézary Syndrome. Curr Hematol Malig Rep 2017;12:234-43. [PMID: 28540671 DOI: 10.1007/s11899-017-0387-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
19 Stranzenbach R, Theurich S, Schlaak M. [Role of stem cell transplantation in treatment of primary cutaneous T‑cell lymphoma]. Hautarzt 2017;68:716-20. [PMID: 28785925 DOI: 10.1007/s00105-017-4023-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
20 Şanlı H, Akay BN, Saral S, Okçu Heper A, Topçuoğlu P. Unique Presentation of Leukemic Cutaneous CD3/TCR- Phenotype T-Cell Lymphoma with Complete Remission after Allogeneic Stem Cell Transplantation. Turk J Haematol 2017;34:194-5. [PMID: 28008858 DOI: 10.4274/tjh.2016.0395] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
21 Hoppe RT, Kim YH, Advani RH. Mycosis Fungoides and Sézary Syndrome. Holland-Frei Cancer Medicine 2017. [DOI: 10.1002/9781119000822.hfcm121] [Reference Citation Analysis]
22 Smith GL. Radiation Therapy in the Management of Cutaneous T-Cell Lymphomas. Radiation Therapy in Hematologic Malignancies 2017. [DOI: 10.1007/978-3-319-42615-0_12] [Reference Citation Analysis]
23 Nicolay JP, Goerdt S. Kutane Lymphome beim alten und geriatrischen Patienten. Geriatrische Onkologie 2017. [DOI: 10.1007/978-3-662-49083-9_43-1] [Reference Citation Analysis]
24 Winsett F, Ni X, Duvic M. Mogamulizumab in the treatment of cutaneous T cell lymphoma. Expert Opinion on Orphan Drugs 2016;4:1277-80. [DOI: 10.1080/21678707.2016.1253469] [Reference Citation Analysis]
25 Patir P, Vural F. Treatment of mycosis fungoides, in the era of stem cell transplantation. World J Dermatol 2016; 5(1): 52-56 [DOI: 10.5314/wjd.v5.i1.52] [Reference Citation Analysis]
26 Smith GL, Wilson LD, Dabaja BS. Mycosis Fungoides. Clinical Radiation Oncology 2016. [DOI: 10.1016/b978-0-323-24098-7.00079-4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
27 Zain J, Thomas SH. Hematopoietic Cell Transplantation for Non'Hodgkin Lymphoma (T Cell). Thomas’ Hematopoietic Cell Transplantation 2016. [DOI: 10.1002/9781118416426.ch58] [Reference Citation Analysis]
28 Hosing C, Bassett R, Dabaja B, Talpur R, Alousi A, Ciurea S, Popat U, Qazilbash M, Shpall EJ, Oki Y, Nieto Y, Pinnix C, Fanale M, Maadani F, Donato M, Champlin R, Duvic M. Allogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institution. Ann Oncol 2015;26:2490-5. [PMID: 26416896 DOI: 10.1093/annonc/mdv473] [Cited by in Crossref: 67] [Cited by in F6Publishing: 69] [Article Influence: 8.4] [Reference Citation Analysis]
29 Perrone G, De Philippis C, Farina L, Corradini P. Peripheral T-cell lymphomas. Clinical Guide to Transplantation in Lymphoma 2015. [DOI: 10.1002/9781118863282.ch19] [Reference Citation Analysis]
30 Jacobsen ED. Stem cell transplantation for mycosis fungoides/Sézary syndrome. Clinical Guide to Transplantation in Lymphoma 2015. [DOI: 10.1002/9781118863282.ch23] [Reference Citation Analysis]
31 Shiue LH, Couturier J, Lewis DE, Wei C, Ni X, Duvic M. The effect of extracorporeal photopheresis alone or in combination therapy on circulating CD4(+) Foxp3(+) CD25(-) T cells in patients with leukemic cutaneous T-cell lymphoma. Photodermatol Photoimmunol Photomed 2015;31:184-94. [PMID: 25772268 DOI: 10.1111/phpp.12175] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
32 Duvic M, Pinter-Brown LC, Foss FM, Sokol L, Jorgensen JL, Challagundla P, Dwyer KM, Zhang X, Kurman MR, Ballerini R, Liu L, Kim YH. Phase 1/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma. Blood 2015;125:1883-9. [PMID: 25605368 DOI: 10.1182/blood-2014-09-600924] [Cited by in Crossref: 161] [Cited by in F6Publishing: 167] [Article Influence: 20.1] [Reference Citation Analysis]
33 Pawar R, Kasi Loknath Kumar A, Woodroof J, Cui W, McGuirk J, Abhyankar S, Ganguly S, Singh A, Lin T, Aljitawi O. Skin Recurrence of Transformed Mycosis Fungoides Postumbilical Cord Blood Transplant despite Complete Donor Chimerism. Case Rep Hematol 2014;2014:743856. [PMID: 25580315 DOI: 10.1155/2014/743856] [Reference Citation Analysis]
34 Goyal A, Carter JB, Sohani AR, Barnes JA, Hoang MP, Duncan LM. Sézary Syndrome. Atlas of Cutaneous Lymphomas 2015. [DOI: 10.1007/978-3-319-17217-0_6] [Reference Citation Analysis]
35 Venkatarajan S, Duvic M. Sézary syndrome: an overview of current and future treatment options. Expert Opinion on Orphan Drugs 2014;2:889-901. [DOI: 10.1517/21678707.2014.928616] [Reference Citation Analysis]
36 Lechowicz MJ, Lazarus HM, Carreras J, Laport GG, Cutler CS, Wiernik PH, Hale GA, Maharaj D, Gale RP, Rowlings PA. Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome. Bone Marrow Transplant. 2014;49:1360-1365. [PMID: 25068422 DOI: 10.1038/bmt.2014.161] [Cited by in Crossref: 66] [Cited by in F6Publishing: 70] [Article Influence: 7.3] [Reference Citation Analysis]
37 Dugas-breit S, Schulze H, Hallermann C. Neue und altbewährte Therapieoptionen bei Mycosis fungoides und Sézary-Syndrom - eine aktuelle Bestandsaufnahme. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 2014;12:561-570. [DOI: 10.1111/ddg.12376_suppl] [Reference Citation Analysis]
38 Child F, Whittaker S. Primary Cutaneous T-cell Lymphoma. Evidence-Based Dermatology 2014. [DOI: 10.1002/9781118357606.ch34] [Reference Citation Analysis]
39 Ram-wolff C. Linfomas T cutáneos de tipo micosis fungoide/síndrome de Sézary (incluida parapsoriasis). EMC - Dermatología 2014;48:1-12. [DOI: 10.1016/s1761-2896(14)67581-6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
40 Zain J, Weichenthal M, Rodig S, Delabie J. Cutaneous T-Cell Lymphoma. Rare Lymphomas 2014. [DOI: 10.1007/978-3-642-39590-1_8] [Reference Citation Analysis]
41 Querfeld C, Rosen ST. Cutaneous T-Cell Lymphoma and Cutaneous B-Cell Lymphoma. Abeloff's Clinical Oncology 2014. [DOI: 10.1016/b978-1-4557-2865-7.00107-7] [Reference Citation Analysis]
42 de Masson A, Beylot-Barry M, Bouaziz JD, Peffault de Latour R, Aubin F, Garciaz S, d’Incan M, Dereure O, Dalle S, Dompmartin A. Allogeneic stem cell transplantation for advanced cutaneous T-cell lymphomas: a study from the French Society of Bone Marrow Transplantation and French Study Group on Cutaneous Lymphomas. Haematologica. 2014;99:527-534. [PMID: 24213148 DOI: 10.3324/haematol.2013.098145] [Cited by in Crossref: 59] [Cited by in F6Publishing: 60] [Article Influence: 5.9] [Reference Citation Analysis]
43 Moritz RK, Ditschkowski M, Klemke CD, Terras S, Schlaak M, Knorr M, Theurich S, Hegenbart U, Kremens B, Beelen DW, Stücker M, Kreuter A; working group "cutaneous lymphomas" of the Arbeitsgemeinschaft für Dermatologische Forschung (ADF), Germany. Allogeneic stem cell transplantation in patients with aggressive primary cutaneous T-cell lymphoma - a case series of the ADF working group "cutaneous lymphomas". J Dtsch Dermatol Ges 2014;12:39-46. [PMID: 24134607 DOI: 10.1111/ddg.12212] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
44 Illidge T, Chan C, Counsell N, Morris S, Scarisbrick J, Gilson D, Popova B, Patrick P, Smith P, Whittaker S, Cowan R. Phase II study of gemcitabine and bexarotene (GEMBEX) in the treatment of cutaneous T-cell lymphoma. Br J Cancer 2013;109:2566-73. [PMID: 24136145 DOI: 10.1038/bjc.2013.616] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
45 Schlaak M, Pickenhain J, Theurich S, Skoetz N, von Bergwelt-Baildon M, Kurschat P. Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T-cell lymphoma. Cochrane Database Syst Rev 2013;:CD008908. [PMID: 23986525 DOI: 10.1002/14651858.CD008908.pub3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
46 Mazzeo E, Rubino L, Buglione M, Antognoni P, Magrini SM, Bertoni F, Parmiggiani M, Barbieri P, Bertoni F. The current management of mycosis fungoides and Sézary syndrome and the role of radiotherapy: Principles and indications. Rep Pract Oncol Radiother 2014;19:77-91. [PMID: 24936325 DOI: 10.1016/j.rpor.2013.07.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
47 Zhang L, Zhang YZ. Reduced-intensity conditioning allogeneic stem cell transplantation in malignant lymphoma: current status. Cancer Biol Med 2013;10:1-9. [PMID: 23691438 DOI: 10.7497/j.issn.2095-3941.2013.01.001] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
48 Khouri IF, Champlin RE. Nonmyeloablative allogeneic stem cell transplantation for non-hodgkin lymphoma. Cancer J 2012;18:457-62. [PMID: 23006952 DOI: 10.1097/PPO.0b013e31826b124c] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
49 Duvic M. Cutaneous T-Cell Lymphomas: Mycosis Fungoides and Sézary Syndrome. Lymphoma 2013. [DOI: 10.1007/978-1-62703-408-1_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
50 Hosing C, Champlin RE. Stem Cell Transplantation for Non-Hodgkin’s Lymphomas. Lymphoma 2013. [DOI: 10.1007/978-1-62703-408-1_23] [Reference Citation Analysis]
51 Ram-wolff C, Laroche L, Wechsler J. Mycosis fongoïde érythrodermique et syndrome de Sézary. Les lymphomes cutanés 2013. [DOI: 10.1007/978-2-8178-0354-8_6] [Reference Citation Analysis]
52 Talpur R, Singh L, Daulat S, Liu P, Seyfer S, Trynosky T, Wei W, Duvic M. Long-term outcomes of 1,263 patients with mycosis fungoides and Sézary syndrome from 1982 to 2009. Clin Cancer Res. 2012;18:5051-5060. [PMID: 22850569 DOI: 10.1158/1078-0432.ccr-12-0604] [Cited by in Crossref: 195] [Cited by in F6Publishing: 201] [Article Influence: 17.7] [Reference Citation Analysis]
53 Duhovic C, Child F, Wain EM. Management of cutaneous T-cell lymphoma. Clin Med (Lond) 2012;12:160-4. [PMID: 22586794 DOI: 10.7861/clinmedicine.12-2-160] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
54 Bloom T, Kuzel TM, Querfeld C, Guitart J, Rosen ST. Cutaneous T-cell lymphomas: a review of new discoveries and treatments. Curr Treat Options Oncol 2012;13:102-21. [PMID: 22311555 DOI: 10.1007/s11864-011-0179-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
55 Li JY, Horwitz S, Moskowitz A, Myskowski PL, Pulitzer M, Querfeld C. Management of cutaneous T cell lymphoma: new and emerging targets and treatment options. Cancer Manag Res 2012;4:75-89. [PMID: 22457602 DOI: 10.2147/CMAR.S9660] [Cited by in Crossref: 3] [Cited by in F6Publishing: 13] [Article Influence: 0.3] [Reference Citation Analysis]
56 Gulia A, Massone C. Primary cutaneous T-cell lymphomas. Journal of the Egyptian Womenʼs Dermatologic Society 2012;9:1-13. [DOI: 10.1097/01.ewx.0000407896.95730.63] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
57 van Besien K. Current status of allogeneic transplantation for aggressive non-Hodgkin lymphoma. Curr Opin Oncol 2011;23:681-91. [PMID: 21946246 DOI: 10.1097/CCO.0b013e32834bb88e] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
58 Paralkar VR, Nasta SD, Morrissey K, Smith J, Vassilev P, Martin ME, Goldstein SC, Loren A, Rook AH, Kim EJ, Porter DL. Allogeneic hematopoietic SCT for primary cutaneous T cell lymphomas. Bone Marrow Transplant 2012;47:940-5. [PMID: 22020023 DOI: 10.1038/bmt.2011.201] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
59 Battistella M. [Cutaneous lymphoma at the Dermatology Day conference, Paris 2010]. Ann Dermatol Venereol 2011;138:H1-11. [PMID: 21703464 DOI: 10.1016/S0151-9638(11)70070-9] [Reference Citation Analysis]
60 Schmitz S. Von der Wichtigkeit wissenschaftsgetriebener Studien. Best Practice Onkologie 2010;5:1-1. [DOI: 10.1007/s11654-010-0251-z] [Reference Citation Analysis]
61 Porcu P. A look at the National Comprehensive Cancer Network guidelines for cutaneous lymphomas. Clin Lymphoma Myeloma Leuk 2010;10 Suppl 2:S109-11. [PMID: 20826394 DOI: 10.3816/CLML.2010.s.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
62 Devine SM. Hematopoietic stem cell transplantation for cutaneous T-cell lymphoma. Clin Lymphoma Myeloma Leuk 2010;10 Suppl 2:S96-8. [PMID: 20826408 DOI: 10.3816/CLML.2010.s.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]